annual EBITDA:
-$109.63M+$118.17M(+51.88%)Summary
- As of today (September 3, 2025), ARQT annual EBITDA is -$109.63 million, with the most recent change of +$118.17 million (+51.88%) on December 31, 2024.
- During the last 3 years, ARQT annual EBITDA has risen by +$96.28 million (+46.76%).
- ARQT annual EBITDA is now -2569.87% below its all-time high of -$4.11 million, reached on December 31, 2017.
Performance
ARQT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$14.05M+$7.35M(+34.35%)Summary
- As of today (September 3, 2025), ARQT quarterly EBITDA is -$14.05 million, with the most recent change of +$7.35 million (+34.35%) on June 30, 2025.
- Over the past year, ARQT quarterly EBITDA has increased by +$35.68 million (+71.75%).
- ARQT quarterly EBITDA is now -135.98% below its all-time high of -$5.95 million, reached on December 31, 2018.
Performance
ARQT quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$80.25M+$35.68M(+30.78%)Summary
- As of today (September 3, 2025), ARQT TTM EBITDA is -$80.25 million, with the most recent change of +$35.68 million (+30.78%) on June 30, 2025.
- Over the past year, ARQT TTM EBITDA has increased by +$98.04 million (+54.99%).
- ARQT TTM EBITDA is now -942.92% below its all-time high of -$7.70 million, reached on September 1, 2018.
Performance
ARQT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ARQT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.9% | +71.8% | +55.0% |
| 3 y3 years | +46.8% | +78.6% | +68.7% |
| 5 y5 years | -154.6% | +60.5% | +12.4% |
ARQT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.8% | -95.8% | +86.6% | at high | +74.5% |
| 5 y | 5-year | -154.6% | +62.8% | -95.8% | +86.6% | at high | +74.5% |
| alltime | all time | -2569.9% | +62.8% | -136.0% | +86.6% | -942.9% | +74.5% |
ARQT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$14.05M(-34.3%) | -$80.25M(-30.8%) |
| Mar 2025 | - | -$21.40M(+198.3%) | -$115.93M(-7.8%) |
| Dec 2024 | -$109.63M(-51.9%) | -$7.17M(-80.9%) | -$125.80M(-29.9%) |
| Sep 2024 | - | -$37.63M(-24.3%) | -$179.41M(+0.6%) |
| Jun 2024 | - | -$49.73M(+59.1%) | -$178.29M(-8.5%) |
| Mar 2024 | - | -$31.26M(-48.6%) | -$194.85M(-18.6%) |
| Dec 2023 | -$227.79M(-22.7%) | -$60.78M(+66.5%) | -$239.49M(-2.9%) |
| Sep 2023 | - | -$36.52M(-44.9%) | -$246.70M(-21.6%) |
| Jun 2023 | - | -$66.29M(-12.7%) | -$314.70M(+0.2%) |
| Mar 2023 | - | -$75.90M(+11.6%) | -$314.00M(+4.5%) |
| Dec 2022 | -$294.87M(+43.2%) | -$68.00M(-34.9%) | -$300.50M(-1.0%) |
| Sep 2022 | - | -$104.51M(+59.3%) | -$303.58M(+18.6%) |
| Jun 2022 | - | -$65.59M(+5.1%) | -$255.95M(+10.2%) |
| Mar 2022 | - | -$62.40M(-12.2%) | -$232.26M(+12.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$205.90M(+51.9%) | -$71.08M(+24.9%) | -$205.77M(+22.1%) |
| Sep 2021 | - | -$56.89M(+35.8%) | -$168.59M(+12.5%) |
| Jun 2021 | - | -$41.90M(+16.7%) | -$149.84M(+4.4%) |
| Mar 2021 | - | -$35.91M(+5.9%) | -$143.51M(+5.4%) |
| Dec 2020 | -$135.56M(+214.8%) | -$33.90M(-11.1%) | -$136.19M(+18.2%) |
| Sep 2020 | - | -$38.14M(+7.2%) | -$115.23M(+25.8%) |
| Jun 2020 | - | -$35.57M(+24.4%) | -$91.60M(+42.1%) |
| Mar 2020 | - | -$28.59M(+121.0%) | -$64.48M(+50.6%) |
| Dec 2019 | -$43.06M(+118.2%) | -$12.93M(-10.9%) | -$42.83M(+19.5%) |
| Sep 2019 | - | -$14.51M(+71.8%) | -$35.84M(+23.5%) |
| Jun 2019 | - | -$8.45M(+22.0%) | -$29.03M(+41.1%) |
| Mar 2019 | - | -$6.93M(+16.4%) | -$20.58M(+50.8%) |
| Dec 2018 | -$19.73M(+380.6%) | -$5.95M(-22.6%) | -$13.65M(+77.4%) |
| Sep 2018 | - | -$7.70M | -$7.70M |
| Dec 2017 | -$4.11M | - | - |
FAQ
- What is Arcutis Biotherapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. annual EBITDA year-on-year change?
- What is Arcutis Biotherapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Arcutis Biotherapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. TTM EBITDA year-on-year change?
What is Arcutis Biotherapeutics, Inc. annual EBITDA?
The current annual EBITDA of ARQT is -$109.63M
What is the all time high annual EBITDA for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high annual EBITDA is -$4.11M
What is Arcutis Biotherapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, ARQT annual EBITDA has changed by +$118.17M (+51.88%)
What is Arcutis Biotherapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of ARQT is -$14.05M
What is the all time high quarterly EBITDA for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high quarterly EBITDA is -$5.95M
What is Arcutis Biotherapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, ARQT quarterly EBITDA has changed by +$35.68M (+71.75%)
What is Arcutis Biotherapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of ARQT is -$80.25M
What is the all time high TTM EBITDA for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high TTM EBITDA is -$7.70M
What is Arcutis Biotherapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, ARQT TTM EBITDA has changed by +$98.04M (+54.99%)